Molecular detection of drug resistance in human cytomegalovirus (CMV)
Microbiology
Virology
○ Whole blood
○ Plasma
Other Information
○ Specimens submitted for genotyping must have a positive PCR result indicating the presence of CMV DNA
○ Testing will only be performed when anti-viral resistant CMV is suspected. This is characterized by a lack of improvement (or relapse) in CMV viremia or clinical disease during antiviral therapy (for > 6 weeks) ○ Upon special request, region of UL56 and UL89 can be assessed for Letermovir resistance.